We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





COVID-19 Face Mask Containing Laser-Induced Graphene Deactivates Coronavirus Under Sunlight

By HospiMedica International staff writers
Posted on 16 Sep 2020
A new anti-bacterial graphene mask developed by scientists at the City University of Hong Kong (Kowloon, Hong Kong) has the potential to combat the novel coronavirus in a quick and cost-effective manner.

Commonly used surgical masks are not antibacterial and allow harmful elements to remain active for hours, posing a risk of secondary infection. More...
However, graphene is known for its anti-bacterial properties which have attracted scientists towards the possibility of making graphene masks. Conventional methods for producing graphene include chemical vapor deposition in which graphene is first grown on a porous substrate at high temperatures and the substrate is subsequently etched; and the hydrothermal method in which graphene oxide collects together and is simultaneously reduced in hot water. However, these two methods have poor control over the shape of the product and require high-temperature conditions, lengthy synthesis routes, and high costs.

In their previous studies, the team of scientists had discovered that direct writing on commercial polyimide films (a polymeric plastic material) or other biomaterials using a commercial CO2 infrared laser system can generate 3D porous graphene, thus making the fabrication of graphene masks quick and easy. Their breakthrough method combines graphene preparation and patterning into a single step. Under computer control, the laser-induced graphene (LIG) can be patterned into various shapes with a porous structure. The masks are made comfortable for breathing by adjusting the laser power to modify the size of the pores. The method is time and cost effective and may help to resolve the problem of sourcing raw materials. Most carbon containing materials, for example cellulose or paper, can be converted into graphene. In addition, the conversion can be carried out under ambient conditions with a laser system found in most machine shops.

Preliminary studies on the anti-bacterial graphene masks are already underway. The LIG material developed by the scientists can kill almost all the E. coli and aerosolized bacteria with the bacteria-killing activity being induced by the graphene-bacteria interactions. Under the photothermal effect of the sun, the scientists found that it was possible to kill bacteria with an efficiency of 99.998% within 10 minutes. In addition, the team has recently begun testing LIG material's ability to combat viruses and has achieved very promising results. Initial tests on two coronaviruses found that the LIG material inactivated over 90% of the virus in five minutes and all of them in 10 minutes. The LIG material has a range of other applications such as fabricating antibacterial medical devices.

The team has also fabricated a hygroelectric generator powered by human breath that can self-report on the condition of a mask. The adhesion of bacteria or atmospheric particles on the LIG changes surface properties and affects moisture-induced potential, which provides information on the condition of a mask. This kind of mask improves the protection effect, which is especially important for frontline workers.

“I think production streamlining should be simple and the price is expected to fall in between that of a surgical mask and a N95 mask,” said Dr. Ye Ruquan, Assistant Professor in the Department of Chemistry at City University of Hong Kong, who discovered the new method for making anti-bacterial graphene masks. “Our next plan is to evaluate the antivirus efficiency and develop a reusable strategy. We have made a face mask prototype, and with an optimal structure, we envision releasing it to the market shortly after obtaining the certified tests.”

Related Links:
City University of Hong Kong


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.